HomeOVID • NASDAQ
add
Ovid Therapeutics Inc
Previous close
$0.29
Day range
$0.27 - $0.30
Year range
$0.24 - $3.45
Market cap
19.23M USD
Avg Volume
383.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 76.00K | -46.48% |
Operating expense | 11.00M | -33.87% |
Net income | -9.25M | 39.61% |
Net profit margin | -12.18K | -12.83% |
Earnings per share | -0.13 | 40.91% |
EBITDA | -10.76M | 34.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 53.08M | -49.85% |
Total assets | 92.17M | -36.01% |
Total liabilities | 23.94M | -57.42% |
Total equity | 68.23M | — |
Shares outstanding | 71.08M | — |
Price to book | 0.30 | — |
Return on assets | -28.03% | — |
Return on capital | -31.32% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -9.25M | 39.61% |
Cash from operations | -10.01M | 15.98% |
Cash from investing | 21.29M | 143.89% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 11.28M | 137.13% |
Free cash flow | -6.28M | -33.39% |
About
Founded
2014
Website
Employees
23
